BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 9408291)

  • 1. Results of contact beta-irradiation of choroidal melanomas.
    Damjanovich J; Berta A; Vezendi L
    Acta Chir Hung; 1997; 36(1-4):67-8. PubMed ID: 9408291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of choroid melanoma with contact curietherapy using ruthenium 106].
    Muller RP; Busse H; Kroll P; Gast E
    J Fr Ophtalmol; 1985; 8(10):639-43. PubMed ID: 3833880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Need for confirmation of positioning of ruthenium plaques by postoperative B-scan ultrasonography.
    Anteby II; Pe'er J
    Ophthalmic Surg Lasers; 1996 Dec; 27(12):1024-9. PubMed ID: 8976522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of medium choroidal melanomas treated with ruthenium brachytherapy guided by three-dimensional pretreatment modeling.
    Browne AW; Dandapani SV; Jennelle R; Stevanovic M; Lee TC; Murphree AL; Kampp TD; Astrahan MA; Kim JW; Berry JL
    Brachytherapy; 2015; 14(5):718-25. PubMed ID: 26073224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Echographic evaluation of choroidal melanomas treated with ruthenium-106 plaques: the treatment failures.
    Perri P; Police G; Pastena B; Ravalli L; Grande L; Rossi A
    Ophthalmologica; 1998; 212 Suppl 1():33-6. PubMed ID: 9730745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Retrospective analysis of ruthenium-106 brachytherapy for small and medium-sized malignant melanoma of the posterior choroid].
    Stoffelns BM; Kutzner J; Jochem T
    Klin Monbl Augenheilkd; 2002 Apr; 219(4):216-20. PubMed ID: 12022004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Radiotherapy of intraocular tumors with Ruthenium-106-containing, beta-emitting ophthalmic applicators. Experiences with treatments performed between 1986 and 1999 in Hungary].
    Berta A
    Magy Onkol; 2005; 49(1):53-7. PubMed ID: 15902335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ruthenium applicators in the treatment of choroidal melanomas.
    Van Hijfte R; Verbraeken H; De Laey JJ
    Bull Soc Belge Ophtalmol; 1987; 224():51-8. PubMed ID: 3509023
    [No Abstract]   [Full Text] [Related]  

  • 9. Fluorescein angiography in the follow-up study of choroidal melanoma after 106Ru/106Rh plaque therapy.
    Lommatzsch PK; Ballin RE; Helm W
    Retina; 1987; 7(3):148-55. PubMed ID: 3423430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Echographic follow-up of malignant melanoma of the choroid after brachytherapy with 106Ru.
    Novak-Andrejcic K; Jancar B; Hawlina M
    Klin Monbl Augenheilkd; 2003 Dec; 220(12):853-60. PubMed ID: 14704943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indocyanine green angiography versus fluorescein angiography in the follow-up of choroidal melanomas treated with RU106/RH106.
    Sallet G; Amoaku WM; Lafaut BA; Van Liefferinge B; De Laey JJ
    Bull Soc Belge Ophtalmol; 1996; 263():27-37. PubMed ID: 9396191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Predictors of Regression of Choroidal Melanomas after Brachytherapy: A Growth Curve Model.
    Rashid M; Heikkonen J; Singh AD; Kivelä TT
    Ophthalmology; 2018 May; 125(5):747-754. PubMed ID: 29499831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ruthenium-106 versus iodine-125 plaque brachytherapy of 571 choroidal melanomas with a thickness of ≥5.5 mm.
    Filì M; Trocme E; Bergman L; See TRO; André H; Bartuma K; Girnita L; All-Eriksson C; Seregard S; Stålhammar G
    Br J Ophthalmol; 2020 Jan; 104(1):26-32. PubMed ID: 30910871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and treatment control of choroidal melanomas--the role of B-scan and Doppler-technique.
    Guthoff R; Winkler P; Helmke K; Berger R
    Acta Ophthalmol Suppl (1985); 1992; (204):59-61. PubMed ID: 1332396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blue-Light Fundus Autofluorescence Imaging following Ruthenium-106 Brachytherapy for Choroidal Melanoma.
    Bindewald-Wittich A; Swenshon T; Carasco E; Dreyhaupt J; Willerding GD
    Ophthalmologica; 2020; 243(4):303-315. PubMed ID: 31940652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Choroidal metastasis of cutaneous malignant melanoma treated by ruthenium-106 plaque irradiation.
    Anteby I; Axer-Siegel R; Pe'er J
    Ann Ophthalmol; 1993 Sep; 25(9):339-41. PubMed ID: 8297070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results after beta-irradiation (106Ru/106Rh) of choroidal melanomas: 20 years' experience.
    Lommatzsch PK
    Br J Ophthalmol; 1986 Nov; 70(11):844-51. PubMed ID: 3790487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant melanomas of the choroid and ruthenium applicators.
    Huyghe JP; Verbraeken H; Goes F; De Wilde G; Hanssens M; Brabant P; Van Hijfte R; De Laey JJ
    Bull Soc Belge Ophtalmol; 1990; 238():137-43. PubMed ID: 2131116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microcirculation patterns in indocyanine green angiography and the results of plaque therapy in choroidal melanoma.
    Kubicka-Trzaska A; Romanowska-Dixon B
    Klin Oczna; 2011; 113(10-12):307-13. PubMed ID: 22384646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An inexpensive fiberoptic light pipe to aid in placement of episcleral radioactive plaques.
    Snyder WB; Fuller DG; Fish GE
    Ophthalmic Surg; 1988 Jan; 19(1):62-3. PubMed ID: 3340406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.